BioCentury
ARTICLE | Clinical News

Pradaxa dabigatran etexilate regulatory update

June 16, 2008 7:00 AM UTC

The Scottish Medicines Consortium recommended the use of Boehringer's Pradaxa dabigatran etexilate on the National Health Service (NHS) in Scotland to prevent venous thromboembolism (VTE) in patients ...